🟢 Moleculin Biotech is trading 5% up today as broader risk appetite returned across growth stocks

Moleculin Biotech is trading 5.41% up now at $0.77 as broader risk appetite returned across growth stocks on September 17, 2026.

• No new company-specific announcement or filing clearly explains the move; the latest identified company news concerns Annamycin presentations announced September 14.
• Biotech’s XBI sector benchmark is up 2.55%, while the Nasdaq is up 1.28%, supporting a sector- and market-driven explanation.